335 related articles for article (PubMed ID: 30052811)
21. Antiretroviral treatment of adult HIV infection: 2008 recommendations of the International AIDS Society-USA panel.
Hammer SM; Eron JJ; Reiss P; Schooley RT; Thompson MA; Walmsley S; Cahn P; Fischl MA; Gatell JM; Hirsch MS; Jacobsen DM; Montaner JS; Richman DD; Yeni PG; Volberding PA;
JAMA; 2008 Aug; 300(5):555-70. PubMed ID: 18677028
[TBL] [Abstract][Full Text] [Related]
22. A viral genome wide association study and genotypic resistance testing in patients failing first line antiretroviral therapy in the first large countrywide Ethiopian HIV cohort.
Telele NF; Kalu AW; Gebre-Selassie S; Fekade D; Marrone G; Grossmann S; Neogi U; Tegbaru B; Sönnerborg A
BMC Infect Dis; 2019 Jul; 19(1):569. PubMed ID: 31262272
[TBL] [Abstract][Full Text] [Related]
23. Low Incidence of HIV-1C Acquired Drug Resistance 10 Years after Roll-Out of Antiretroviral Therapy in Ethiopia: A Prospective Cohort Study.
Mulu A; Maier M; Liebert UG
PLoS One; 2015; 10(10):e0141318. PubMed ID: 26512902
[TBL] [Abstract][Full Text] [Related]
24. Treatment for adult HIV infection: 2006 recommendations of the International AIDS Society-USA panel.
Hammer SM; Saag MS; Schechter M; Montaner JS; Schooley RT; Jacobsen DM; Thompson MA; Carpenter CC; Fischl MA; Gazzard BG; Gatell JM; Hirsch MS; Katzenstein DA; Richman DD; Vella S; Yeni PG; Volberding PA;
JAMA; 2006 Aug; 296(7):827-43. PubMed ID: 16905788
[TBL] [Abstract][Full Text] [Related]
25. Comparative analysis of drug resistance mutations in the human immunodeficiency virus reverse transcriptase gene in patients who are non-responsive, responsive and naive to antiretroviral therapy.
Misbah M; Roy G; Shahid M; Nag N; Kumar S; Husain M
Arch Virol; 2016 May; 161(5):1101-13. PubMed ID: 26801790
[TBL] [Abstract][Full Text] [Related]
26. Low-Abundance Drug-Resistant HIV-1 Variants in Antiretroviral Drug-Naive Individuals: A Systematic Review of Detection Methods, Prevalence, and Clinical Impact.
Mbunkah HA; Bertagnolio S; Hamers RL; Hunt G; Inzaule S; Rinke De Wit TF; Paredes R; Parkin NT; Jordan MR; Metzner KJ;
J Infect Dis; 2020 Apr; 221(10):1584-1597. PubMed ID: 31809534
[TBL] [Abstract][Full Text] [Related]
27. Molecular basis of human immunodeficiency virus type 1 drug resistance: overview and recent developments.
Menéndez-Arias L
Antiviral Res; 2013 Apr; 98(1):93-120. PubMed ID: 23403210
[TBL] [Abstract][Full Text] [Related]
28. Patterns of HIV-1 drug resistance after first-line antiretroviral therapy (ART) failure in 6 sub-Saharan African countries: implications for second-line ART strategies.
Hamers RL; Sigaloff KC; Wensing AM; Wallis CL; Kityo C; Siwale M; Mandaliya K; Ive P; Botes ME; Wellington M; Osibogun A; Stevens WS; Rinke de Wit TF; Schuurman R;
Clin Infect Dis; 2012 Jun; 54(11):1660-9. PubMed ID: 22474222
[TBL] [Abstract][Full Text] [Related]
29. Pretreatment HIV-drug resistance in Mexico and its impact on the effectiveness of first-line antiretroviral therapy: a nationally representative 2015 WHO survey.
Ávila-Ríos S; García-Morales C; Matías-Florentino M; Romero-Mora KA; Tapia-Trejo D; Quiroz-Morales VS; Reyes-Gopar H; Ji H; Sandstrom P; Casillas-Rodríguez J; Sierra-Madero J; León-Juárez EA; Valenzuela-Lara M; Magis-Rodríguez C; Uribe-Zuñiga P; Reyes-Terán G;
Lancet HIV; 2016 Dec; 3(12):e579-e591. PubMed ID: 27658867
[TBL] [Abstract][Full Text] [Related]
30. Incidence of transmitted antiretroviral drug resistance in treatment-naive HIV-1-infected persons in a large South Central United States clinic.
Kleyn TJ; Liedtke MD; Harrison DL; Lockhart SM; Salvaggio MR; Ripley TL; Rathbun RC
Ann Pharmacother; 2014 Apr; 48(4):470-5. PubMed ID: 24473489
[TBL] [Abstract][Full Text] [Related]
31. RNA and DNA Sanger sequencing versus next-generation sequencing for HIV-1 drug resistance testing in treatment-naive patients.
Alidjinou EK; Deldalle J; Hallaert C; Robineau O; Ajana F; Choisy P; Hober D; Bocket L
J Antimicrob Chemother; 2017 Oct; 72(10):2823-2830. PubMed ID: 29091197
[TBL] [Abstract][Full Text] [Related]
32. Clinical utility of testing human immunodeficiency virus for drug resistance.
Harrigan PR; Côté HC
Clin Infect Dis; 2000 Jun; 30 Suppl 2():S117-22. PubMed ID: 10860895
[TBL] [Abstract][Full Text] [Related]
33. European recommendations for the clinical use of HIV drug resistance testing: 2011 update.
Vandamme AM; Camacho RJ; Ceccherini-Silberstein F; de Luca A; Palmisano L; Paraskevis D; Paredes R; Poljak M; Schmit JC; Soriano V; Walter H; Sönnerborg A;
AIDS Rev; 2011; 13(2):77-108. PubMed ID: 21587341
[TBL] [Abstract][Full Text] [Related]
34. Multimethod Longitudinal HIV Drug Resistance Analysis in Antiretroviral-Therapy-Naive Patients.
Nanfack AJ; Redd AD; Bimela JS; Ncham G; Achem E; Banin AN; Kirkpatrick AR; Porcella SF; Agyingi LA; Meli J; Colizzi V; Nádas A; Gorny MK; Nyambi PN; Quinn TC; Duerr R
J Clin Microbiol; 2017 Sep; 55(9):2785-2800. PubMed ID: 28659324
[TBL] [Abstract][Full Text] [Related]
35. Genetic Diversity and Drug Resistance Among Antiretroviral Treatment-Failed Individuals from 2010 to 2012 in Honghe, China.
Yang C; Yang S; Li J; Yang B; Liu J; Li H; Bian Z
AIDS Res Hum Retroviruses; 2015 Aug; 31(8):822-9. PubMed ID: 25919896
[TBL] [Abstract][Full Text] [Related]
36. Low rate of genotypic HIV-1 drug-resistant strains in the Senegalese government initiative of access to antiretroviral therapy.
Vergne L; Kane CT; Laurent C; Diakhaté N; Gueye NF; Gueye PM; Sow PS; Faye MA; Liégeois F; Ndir A; Lanièce I; Peeters M; Ndoye I; Mboup S; Delaporte E
AIDS; 2003 Jul; 17 Suppl 3():S31-8. PubMed ID: 14565607
[TBL] [Abstract][Full Text] [Related]
37. Low-abundance drug-resistant viral variants in chronically HIV-infected, antiretroviral treatment-naive patients significantly impact treatment outcomes.
Simen BB; Simons JF; Hullsiek KH; Novak RM; Macarthur RD; Baxter JD; Huang C; Lubeski C; Turenchalk GS; Braverman MS; Desany B; Rothberg JM; Egholm M; Kozal MJ;
J Infect Dis; 2009 Mar; 199(5):693-701. PubMed ID: 19210162
[TBL] [Abstract][Full Text] [Related]
38. Executive summary of the GESIDA/National AIDS Plan Consensus Document on antiretroviral therapy in adults infected by the human immunodeficiency virus (updated January 2015).
; Berenguer J; Polo R; Aldeguer JL; Lozano F; Aguirrebengoa K; Arribas JR; Blanco JR; Boix V; Casado JL; Clotet B; Crespo M; Domingo P; Estrada V; García F; Gatell JM; González-García J; Gutiérrez F; Iribarren JA; Knobel H; Llibre JM; Locutura J; López JC; Miró JM; Moreno S; Podzamczer D; Portilla J; Pulido F; Ribera E; Riera M; Rubio R; Santos J; Sanz-Moreno J; Sanz J; Téllez MJ; Tuset M; Rivero A
Enferm Infecc Microbiol Clin; 2015 Oct; 33(8):544-56. PubMed ID: 26021186
[TBL] [Abstract][Full Text] [Related]
39. Treatment-naive individuals are the major source of transmitted HIV-1 drug resistance in men who have sex with men in the Swiss HIV Cohort Study.
Drescher SM; von Wyl V; Yang WL; Böni J; Yerly S; Shah C; Aubert V; Klimkait T; Taffé P; Furrer H; Battegay M; Ambrosioni J; Cavassini M; Bernasconi E; Vernazza PL; Ledergerber B; Günthard HF; Kouyos RD;
Clin Infect Dis; 2014 Jan; 58(2):285-94. PubMed ID: 24145874
[TBL] [Abstract][Full Text] [Related]
40. [GeSIDA/National AIDS Plan: Consensus document on antiretroviral therapy in adults infected by the human immunodeficiency virus (Updated January 2014)].
;
Enferm Infecc Microbiol Clin; 2014; 32(7):446.e1-42. PubMed ID: 24953253
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
